In spite of the challenges posed by the COVID-19 pandemic, the global malaria community has shown remarkable resilience and commitment to fight this deadly disease. The 2022 World malaria report¹ revealed that malaria cases and deaths remained stable in 2021, thanks to the efforts of countries and partners to sustain and scale up essential malaria services. However, more needs to be done to achieve the global targets of reducing malaria cases and deaths by at least 90 per cent by 2030². With new tools and innovations on the horizon, such as the first WHO-approved malaria vaccine for at-risk children and new insecticide-treated bed nets, there is hope that we can accelerate progress towards malaria control and elimination in the coming years³.
Every year on April 25th, we observe World Malaria Day to raise awareness and mobilise action against malaria. This year, the World Health Organisation’s call to action focuses on three key areas: investing in the global malaria response, stepping up innovation, and implementing the strategies we have now. MalariaGEN and its partners are contributing to the global effort to tackle malaria by harnessing the power of genomic surveillance, and we’re taking a look at how this work aligns with the WHO’s three key areas.